Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
44.05
-2.80 (-5.98%)
May 5, 2025, 4:00 PM EDT - Market closed
Guardant Health Employees
As of December 31, 2024, Guardant Health had 2,021 total employees, including 1,999 full-time and 22 part-time employees. The number of employees increased by 242 or 13.60% compared to the previous year.
Employees
2,021
Change (1Y)
242
Growth (1Y)
13.60%
Revenue / Employee
$382,977
Profits / Employee
-$206,109
Market Cap
5.46B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
GH News
- 4 days ago - Guardant Health: Tailwinds Are Beginning To Impact The Financials - Seeking Alpha
- 5 days ago - Guardant Health, Inc. (GH) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Guardant Health Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance - Business Wire
- 6 days ago - Guardant Health Presents Data Demonstrating Strong Performance of Shield Multi-Cancer Detection Test Across 10 Tumor Types - Business Wire
- 7 days ago - CORRECTING and REPLACING Guardant Health Launches Guardant360 Tissue, First Tissue Molecular Profiling Test with Comprehensive Multiomic Analysis to Provide a More Complete View of Cancer - Business Wire
- 7 days ago - Guardant Health Launches Guardant360 Tissue, First Tissue Molecular Profiling Test with Comprehensive Multiomic Analysis to Provide a More Complete View of Cancer - Business Wire
- 11 days ago - Guardant Health Announces Strategic Collaboration With Pfizer to Support Development and Commercialization of New Cancer Therapies Using Guardant Infinity Smart Liquid Biopsy Platform - Business Wire
- 13 days ago - Guardant Health to Present Data Highlighting Advances in Multi-Cancer Detection and Liquid and Tissue Molecular Profiling at AACR - Business Wire